Prostate brachytherapy utilization in the COVID-19 era: A cross-sectional study of radiation oncologists in the United States

PURPOSE: Despite advantages such as abbreviated treatment course, brachytherapy (BT) utilization rates for prostate cancer (PC) in the United States (US) are declining. We surveyed practicing US radiation oncologists (ROs) to determine the proportion who offer BT for PC and whether the COVID-19 pand...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Rahul N., Gokun, Yevgeniya, Ritter, Alex R., Jhawar, Sachin R., Vudatala, Sundari, Wang, Shang-Jui, Martin, Douglas, Diaz, Dayssy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Brachytherapy Society. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489987/
https://www.ncbi.nlm.nih.gov/pubmed/36347762
http://dx.doi.org/10.1016/j.brachy.2022.08.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489987/
https://www.ncbi.nlm.nih.gov/pubmed/36347762
http://dx.doi.org/10.1016/j.brachy.2022.08.016

Ejemplares similares